Mackenzie Financial’s CONMED CNMD Stock Holding History

Mackenzie Financial’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$290K	Sell	6,278 -220	-3%	-$10.1K	﹤0.01%	1413
2026 Q2	$213K	Buy	+6,498	New	+$234K	﹤0.01%	1481
2023 Q3	–	Sell	-1,753	Closed	-$235K	–	1491
2023 Q2	$235K	Buy	+1,753	New	+$214K	﹤0.01%	1271
2022 Q2	–	Sell	-1,645	Closed	-$244K	–	1472
2022 Q1	$244K	Buy	1,645 +73	+5%	+$10.2K	﹤0.01%	1211
2021 Q4	$223K	Sell	1,572 -132	-8%	-$18.7K	﹤0.01%	1287
2021 Q3	$223K	Buy	+1,704	New	+$223K	﹤0.01%	1267
2016 Q4	–	Sell	-9,713	Closed	-$389K	–	655
2016 Q3	$389K	Hold	9,713	–	–	﹤0.01%	530
2016 Q2	$464K	Hold	9,713	–	–	﹤0.01%	769
2016 Q1	$407K	Hold	9,713	–	–	﹤0.01%	690
2015 Q4	$428K	Buy	+9,713	New	+$422K	﹤0.01%	699

Other funds holding CNMD

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Mackenzie Financial's CNMD Position: Q3 2026 in Review

Mackenzie Financial reduced its CONMED (CNMD) stake by 3.4% in Q3 2026, selling an estimated $10.1K and leaving 6,278 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Mackenzie Financial first reported a position in CNMD in Q4 2015 and has held it in 10 quarters since. The position peaked at $464K in Q2 2016. 213 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

Mackenzie Financial held 6,278 shares of CONMED worth $290K as of Q3 2026.
Mackenzie Financial sold 220 CONMED shares in Q3 2026, an estimated $10.1K.
CONMED made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1413 holding.
Mackenzie Financial first reported a position in CONMED in Q4 2015 and has held it in 10 quarters since.
Mackenzie Financial's CONMED position peaked at $464K in Q2 2016.
213 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.